Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Gains No Impartiality Benefit From Conflict-Of-Interest Policy, Advocates Say

Aug 01 2011

• By Cathy Dombrowski

Related Content

FDA Advisory Committee Waivers Reflect Recruitment Challenges

Aug 01 2011

Conflict-Of-Interest Policy Relaxation For FDA Cmtes. Could Be Easy PDUFA Add-on

Aug 01 2011

FDA Opens De-Regulation Docket To Collect Ideas For Repealing, Modifying Deficient Rules

Apr 26 2011

FDA Considering New Metrics To Evaluate Advisory Panel Member Conflicts

Sep 11 2006

Advisory Panelist Conflicts Of Interest Have Weak Favorable Effect On Votes

May 08 2006

Advisory Committee Conflict Of Interest Waivers Get Support From Study

Nov 26 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window